Manulife (Manufacturers Life Insurance)
MCRB icon

Manulife (Manufacturers Life Insurance)’s Seres Therapeutics MCRB Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-932
Closed -$26.1K – 2976
2023
Q4 		$26.1K Sell
932
-1,065
-53% -$28K ﹤0.01% 2930
2023
Q3 		$95K Hold
1,997
– – ﹤0.01% 2827
2023
Q2 		$191K Buy
1,997
+566
+40% +$61.6K ﹤0.01% 2628
2023
Q1 		$162K Hold
1,431
– – ﹤0.01% 2633
2022
Q4 		$160K Sell
1,431
-135
-9% -$18.1K ﹤0.01% 2656
2022
Q3 		$201K Sell
1,566
-59
-4% -$6.04K ﹤0.01% 2587
2022
Q2 		$111K Buy
1,625
+126
+8% +$10.9K ﹤0.01% 2871
2022
Q1 		$213K Sell
1,499
-352
-19% -$54.1K ﹤0.01% 2731
2021
Q4 		$308 Sell
1,851
-48
-3% -$7.63K ﹤0.01% 2590
2021
Q3 		$264K Sell
1,899
-74
-4% -$14.5K ﹤0.01% 2773
2021
Q2 		$941K Buy
1,973
+399
+25% +$168K ﹤0.01% 2029
2021
Q1 		$648K Sell
1,574
-90
-5% -$41.4K ﹤0.01% 2132
2020
Q4 		$815K Buy
1,664
+133
+9% +$77.9K ﹤0.01% 1939
2020
Q3 		$867K Buy
1,531
+123
+9% +$40.9K ﹤0.01% 1727
2020
Q2 		$131K Buy
1,408
+62
+5% +$5.44K ﹤0.01% 2660
2020
Q1 		$96K Buy
1,346
+90
+7% +$6.04K ﹤0.01% 2589
2019
Q4 		$87K Buy
1,256
+60
+5% +$4.45K ﹤0.01% 2817
2019
Q3 		$94K Buy
+1,196
New +$79K ﹤0.01% 2836
2018
Q3 		– Sell
-997
Closed -$171K – 3498
2018
Q2 		$171K Buy
997
+105
+12% +$17.2K ﹤0.01% 3236
2018
Q1 		$130K Buy
892
+8
+0.9% +$1.53K ﹤0.01% 3320
2017
Q4 		$178K Buy
884
+32
+4% +$6.58K ﹤0.01% 3094
2017
Q3 		$273K Sell
852
-62
-7% -$16.9K ﹤0.01% 2731
2017
Q2 		$206K Buy
914
+121
+15% +$24.8K ﹤0.01% 2987
2017
Q1 		$178K Buy
793
+82
+12% +$16.6K ﹤0.01% 2908
2016
Q4 		$140K Buy
711
+15
+2% +$3.27K ﹤0.01% 3046
2016
Q3 		$171K Buy
696
+41
+6% +$14.4K ﹤0.01% 2884
2016
Q2 		$381K Buy
655
+335
+105% +$197K ﹤0.01% 2211
2016
Q1 		$161K Buy
320
+236
+281% +$123K ﹤0.01% 2752
2015
Q4 		$59 Buy
84
+75
+833% +$49.3K ﹤0.01% 3243
2015
Q3 		$5 Buy
+9
New +$7.34K ﹤0.01% 3685

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MCRB Position: Q1 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Seres Therapeutics (MCRB) in Q1 2024, closing a stake of 932 shares — an estimated $26.1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MCRB in Q3 2015 and held it in 30 quarters. The position peaked at $941K in Q2 2021. 99 funds tracked by Wall St. Rank hold MCRB as of Q1 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Seres Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 932 Seres Therapeutics shares in Q1 2024, an estimated $26.1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Seres Therapeutics in Q3 2015 and held it in 30 quarters.
  • Manulife (Manufacturers Life Insurance)'s Seres Therapeutics position peaked at $941K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2024, filed 14 May 2024.